cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Shahdevi Nandar Kurniawan
Contact Email
shahdevinandar@ub.ac.id
Phone
+62341-321297
Journal Mail Official
jphv@ub.ac.id
Editorial Address
Neurology Department, Faculty of Medicine, Brawijaya University Jl. JA Suprapto No. 2 Malang, Indonesia 65112
Location
Kota malang,
Jawa timur
INDONESIA
Journal of Pain, Vertigo and Headache
Published by Universitas Brawijaya
ISSN : 27233979     EISSN : 27233960     DOI : https://doi.org/10.21776/ub.jphv
Core Subject : Science,
Neuroscience
JPHV - Journal of Pain, Headache and Vertigo is a peer-reviewed and open access journal that focuses on promoting pain, headache and vertigo. This journal publishes original articles, reviews, and also interesting case reports. JPHV - Journal of Pain, Headache and Vertigo is an international scientific journal, published twice a year by PERDOSSI (Perhimpunan Dokter Spesialis Saraf Indonesia Cabang Malang) - Indonesian Neurological Association Branch of Malang cooperated with Neurology Residency Program, Faculty of Medicine Brawijaya University, Malang, Indonesia.
Arjuna Subject : Ilmu Syaraf - Neorologi
Articles 10 Documents
 1 
Search results for , issue "Vol. 1 No. 2 (2020): September" : 10 Documents clear
CARBAMAZEPINE AS A PAIN TREATMENT OF TRIGEMINAL NEURALGIA Hanik Hidayati
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (221.313 KB) | DOI: 10.21776/ub.jphv.2020.001.02.4

Abstract

Pain and fear of pain continue to be the commonest and strongest motivation for the patients to seek medical help. Pain is a personal experience of the sufferer that cannot be shared and wholly belongs to the sufferer. Trigeminal neuralgia (NT) is a notable facial pain disorder resulting in periodic severe pain that produces one of the most severe kinds of pain known to mankind. Treatment of this debilitating condition may be varied, ranging from medical to surgical interventions. Anticonvulsant are commonly used for its treatment. One of anticonvulsant drug is carbamazepine (CBZ). This paper will discuss about the efficacy and tolerability of CBZ for the treatment of NT.
COMPARATIVE OF INTRAARTICULAR INJECTION BETWEEN DEXTROSE PROLOTHERAPY VERSUS TRIAMCINOLONE ACETONIDE IN KNEE OSTEOARTHRITIS Widodo Mardi Santoso; Andhy Indriyono; Badrul Munir; Alidha Nur Rakhmani; Machlusil Husna
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (292.991 KB) | DOI: 10.21776/ub.jphv.2020.001.02.1

Abstract

Knee osteoarthritis (OA) is one of the most common cartilage degenerative disorders that is a major problem because it causes chronic pain and disability. Therefore the method of treatment and prevention of old age is a big challenge. The results of Dextrose Prolotherapy compared to Triamcinolone therapy research are still varied. Objective:  to  compare  the effectiveness  of  Dextrose  Prolotherapy  and  Triamcinolone Acetonide (TA) in the treatment of moderate knee knee OA.True experimental single blind study, at the Neurology Polyclinic Dr. Saiful Anwar General Hospital Malang for 6 months (July-December 2019). Group I; Dextrose Prolotherapy (15%) intraarticularly injected 3 times every 4 weeks and group II; TA one- time intraarticular injection. The parameters studied were The Western Ontario and McMaster  Universities  Osteoarthritis  Index  (WOMAC)  Score,  Numeric  Rating  Scale (NRS), and Range of Motion (ROM), weeks 0, 4, 8, 12 and 24. Forty samples consisted of; the 20 samples of the Dextrose Prolotherapy group consisted of; male: female = 2 (10%): 18 (90%), age 62.4 + 7.28, BMI 25.6 + 3.69 kg / m2, pain duration 22.35 + 20.10 months, history of physiotherapy 40.27 + 20.79 times. Kellgren–Lawrence osteoarthritis severity grade II; 17 (85%), grade III 3 (15%). TA group; male: female = 5 (25%):15 (75%), age 62.5 + 9.02, BMI 28.4 + 5.01 kg/m2, pain duration 15.95 +  16.55  months,  history  of  physiotherapy  34  +  24.87  times.  Kellgren  –  Lawrence osteoarthritis severity grade II; 18 (90%), grade III; 2 (10%). Comparison of NRS at rest Dextrose Prolotherapy vs TA of week 4 (2.60 vs 1.25), week 8 (1.65 vs 1.40), week 12 (0.8 vs 2.05), week 24 (0.75 vs 3.35). Comparison of NRS during activity Dextrose Prolotherapy vs TA week 4 (4.45 vs 3.35), week 8 (3.25 vs 3.55), week 12 (2.55 vs 4.30), week 24 (2.55 vs 5.80). Comparison of ROM flexion Dextrose Prolotherapy vs TA week 4 (127.05° vs 123.60°), week  8  (130.85°  vs  122.95°),  week  12  (130.85°  vs  122.95°),  week  24  (131.05°  vs 122.10°). Comparison of WOMAC score Dextrose Prolotherapy vs TA week 4 (30.05 vs 22.45), week 8 (22.90 vs 23.95), week 12 (19.30 vs 29.05), week 24 (18.95 vs 35.40). Intraarticular Injection Dextrose Prolotherapy is more effective for the long term based on pain scale NRS, WOMAC score and ROM. Whereas short-term TA is more effective than Dextrose Prolotherapy.
STROKE AFTER ELECTRICAL INJURY : CASE REPORT Eko Arisetijono; Catur Ari Setianto; Sri Budi Rianawati; Masruroh Rahayu; Rodhiyan Rakhmatiar
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (226.884 KB) | DOI: 10.21776/ub.jphv.2020.001.02.2

Abstract

Electrical injury ranging widely reported caused variety of clinical manifestations including brain. Cerebral infarction is one of the manifestation either after low or high voltage electrical injury. We report the case of 49 – year old male who suffered a household electrical injury (110 – 220 Volt) while he was installing the light bulb. He found unconsciousness with left hemiparesis and also central paresis of the left facial nerve (Cranial Nerve VII). The Head Computed Tomography Scan (CT scan) showed wide infarction at right hemisphere which the territory of right cerebral media artery which can be caused by electrical injury.     
RADIOFREQUENCY AS PAIN INTERVENTIONAL THERAPY IN NEUROLOGY Badrul Munir; Widodo Mardi Santoso; Zamroni Afif; Shahdevi Nandar Kurniawan
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (234.177 KB) | DOI: 10.21776/ub.jphv.2020.001.02.3

Abstract

Radiofrequency (RF) intervention uses high frequency alternating current (AC) to inhibit and alter nociceptive pathway in various locations. Radiofrequency is divided into Continuous RF (CRF) and Pulsed RF (PRF). Continuous RF is a process in which the RF current is used to produce thermal lesions on the target nerve that will result in resistance to the afferent nociceptive pathway. PRF is a process whereby short bursts of RF are discharged toward a neural target that will produce a signal for lowering pain. PRF is a therapy of neural tissue with small neurodestructive possibility and is an alternative technique for continuing RF. RF therapy is a minimally invasive procedure that has been used for about three decades to treat various chronic pain syndromes such as trigeminal neuralgia, post herpes neuralgia, lower back pain (LBP), and complex regional pain syndromes or sympathetic reflex dystrophy. The mechanism action of the PRF involves cellular structure damage, neuronal activation, altered gene expression, a global continuation of evoked synaptic  activity in pain fibers through centrals and changes in synaptic strength and long-term potentiation.  PRF with its various characteristics has a better outcome than conventional RF.
PARACETAMOL, MIGRAINE, AND MEDICATION OVERUSE HEADACHE (MOH) Hanik Hidayati; Anung Kustriyani
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (242.994 KB) | DOI: 10.21776/ub.jphv.2020.001.02.5

Abstract

Paracetamol is a nonopioid synthesized p-aminophenol derivative that used as an antipyretic and an analgesic. Paracetamol is an over the counter medicine. 15.6% of migraine patients took paracetamol for headache relief. In migraine, paracetamol is used long term. This triggers paracetamol to cause Medication Overuse Headache (MOH). Animal studies associated paracetamol induced MOH based on pathophysiology migrenes. There three mechanism underline MOH include effect to korteks cerebral, effect to system trigeminal nociception, and effect to central modulating systems.
CARBAMAZEPINE AS A PAIN TREATMENT OF TRIGEMINAL NEURALGIA Hanik Hidayati
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jphv.2020.001.02.4

Abstract

Pain and fear of pain continue to be the commonest and strongest motivation for the patients to seek medical help. Pain is a personal experience of the sufferer that cannot be shared and wholly belongs to the sufferer. Trigeminal neuralgia (NT) is a notable facial pain disorder resulting in periodic severe pain that produces one of the most severe kinds of pain known to mankind. Treatment of this debilitating condition may be varied, ranging from medical to surgical interventions. Anticonvulsant are commonly used for its treatment. One of anticonvulsant drug is carbamazepine (CBZ). This paper will discuss about the efficacy and tolerability of CBZ for the treatment of NT.
COMPARATIVE OF INTRAARTICULAR INJECTION BETWEEN DEXTROSE PROLOTHERAPY VERSUS TRIAMCINOLONE ACETONIDE IN KNEE OSTEOARTHRITIS Widodo Mardi Santoso; Andhy Indriyono; Badrul Munir; Alidha Nur Rakhmani; Machlusil Husna
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jphv.2020.001.02.1

Abstract

Knee osteoarthritis (OA) is one of the most common cartilage degenerative disorders that is a major problem because it causes chronic pain and disability. Therefore the method of treatment and prevention of old age is a big challenge. The results of Dextrose Prolotherapy compared to Triamcinolone therapy research are still varied. Objective:  to  compare  the effectiveness  of  Dextrose  Prolotherapy  and  Triamcinolone Acetonide (TA) in the treatment of moderate knee knee OA.True experimental single blind study, at the Neurology Polyclinic Dr. Saiful Anwar General Hospital Malang for 6 months (July-December 2019). Group I; Dextrose Prolotherapy (15%) intraarticularly injected 3 times every 4 weeks and group II; TA one- time intraarticular injection. The parameters studied were The Western Ontario and McMaster  Universities  Osteoarthritis  Index  (WOMAC)  Score,  Numeric  Rating  Scale (NRS), and Range of Motion (ROM), weeks 0, 4, 8, 12 and 24. Forty samples consisted of; the 20 samples of the Dextrose Prolotherapy group consisted of; male: female = 2 (10%): 18 (90%), age 62.4 + 7.28, BMI 25.6 + 3.69 kg / m2, pain duration 22.35 + 20.10 months, history of physiotherapy 40.27 + 20.79 times. Kellgren–Lawrence osteoarthritis severity grade II; 17 (85%), grade III 3 (15%). TA group; male: female = 5 (25%):15 (75%), age 62.5 + 9.02, BMI 28.4 + 5.01 kg/m2, pain duration 15.95 +  16.55  months,  history  of  physiotherapy  34  +  24.87  times.  Kellgren  –  Lawrence osteoarthritis severity grade II; 18 (90%), grade III; 2 (10%). Comparison of NRS at rest Dextrose Prolotherapy vs TA of week 4 (2.60 vs 1.25), week 8 (1.65 vs 1.40), week 12 (0.8 vs 2.05), week 24 (0.75 vs 3.35). Comparison of NRS during activity Dextrose Prolotherapy vs TA week 4 (4.45 vs 3.35), week 8 (3.25 vs 3.55), week 12 (2.55 vs 4.30), week 24 (2.55 vs 5.80). Comparison of ROM flexion Dextrose Prolotherapy vs TA week 4 (127.05° vs 123.60°), week  8  (130.85°  vs  122.95°),  week  12  (130.85°  vs  122.95°),  week  24  (131.05°  vs 122.10°). Comparison of WOMAC score Dextrose Prolotherapy vs TA week 4 (30.05 vs 22.45), week 8 (22.90 vs 23.95), week 12 (19.30 vs 29.05), week 24 (18.95 vs 35.40). Intraarticular Injection Dextrose Prolotherapy is more effective for the long term based on pain scale NRS, WOMAC score and ROM. Whereas short-term TA is more effective than Dextrose Prolotherapy.
STROKE AFTER ELECTRICAL INJURY : CASE REPORT Eko Arisetijono; Catur Ari Setianto; Sri Budi Rianawati; Masruroh Rahayu; Rodhiyan Rakhmatiar
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jphv.2020.001.02.2

Abstract

Electrical injury ranging widely reported caused variety of clinical manifestations including brain. Cerebral infarction is one of the manifestation either after low or high voltage electrical injury. We report the case of 49 – year old male who suffered a household electrical injury (110 – 220 Volt) while he was installing the light bulb. He found unconsciousness with left hemiparesis and also central paresis of the left facial nerve (Cranial Nerve VII). The Head Computed Tomography Scan (CT scan) showed wide infarction at right hemisphere which the territory of right cerebral media artery which can be caused by electrical injury.     
RADIOFREQUENCY AS PAIN INTERVENTIONAL THERAPY IN NEUROLOGY Badrul Munir; Widodo Mardi Santoso; Zamroni Afif; Shahdevi Nandar Kurniawan
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jphv.2020.001.02.3

Abstract

Radiofrequency (RF) intervention uses high frequency alternating current (AC) to inhibit and alter nociceptive pathway in various locations. Radiofrequency is divided into Continuous RF (CRF) and Pulsed RF (PRF). Continuous RF is a process in which the RF current is used to produce thermal lesions on the target nerve that will result in resistance to the afferent nociceptive pathway. PRF is a process whereby short bursts of RF are discharged toward a neural target that will produce a signal for lowering pain. PRF is a therapy of neural tissue with small neurodestructive possibility and is an alternative technique for continuing RF. RF therapy is a minimally invasive procedure that has been used for about three decades to treat various chronic pain syndromes such as trigeminal neuralgia, post herpes neuralgia, lower back pain (LBP), and complex regional pain syndromes or sympathetic reflex dystrophy. The mechanism action of the PRF involves cellular structure damage, neuronal activation, altered gene expression, a global continuation of evoked synaptic  activity in pain fibers through centrals and changes in synaptic strength and long-term potentiation.  PRF with its various characteristics has a better outcome than conventional RF.
PARACETAMOL, MIGRAINE, AND MEDICATION OVERUSE HEADACHE (MOH) Hanik Hidayati; Anung Kustriyani
Journal of Pain, Headache and Vertigo Vol. 1 No. 2 (2020): September
Publisher : Journal of Pain, Headache and Vertigo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jphv.2020.001.02.5

Abstract

Paracetamol is a nonopioid synthesized p-aminophenol derivative that used as an antipyretic and an analgesic. Paracetamol is an over the counter medicine. 15.6% of migraine patients took paracetamol for headache relief. In migraine, paracetamol is used long term. This triggers paracetamol to cause Medication Overuse Headache (MOH). Animal studies associated paracetamol induced MOH based on pathophysiology migrenes. There three mechanism underline MOH include effect to korteks cerebral, effect to system trigeminal nociception, and effect to central modulating systems.

Page 1 of 1 | Total Record : 10

 1 

Filter by Year

2020 2020


Reset
Filter By Issues
All Issue Vol. 4 No. 2 (2023): September Vol. 4 No. 1 (2023): March Vol. 3 No. 2 (2022): September Vol. 3 No. 1 (2022): March Vol. 2 No. 2 (2021): September Vol. 2 No. 1 (2021): March Vol. 1 No. 2 (2020): September Vol. 1 No. 1 (2020): March